Sodium Acetate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Sodium Acetate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Feb 3, 2016.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6261-01
Dosage Form
Injection
Presentation
Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)
Initial Posting
Feb 3, 2016

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.